These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22559065)

  • 1. New subtypes and genetic recombination in HIV type 1-infecting patients with highly active antiretroviral therapy in Peru (2008-2010).
    Yabar CA; Acuña M; Gazzo C; Salinas G; Cárdenas F; Valverde A; Romero S
    AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1712-22. PubMed ID: 22559065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular diversity of HIV-1 and surveillance of transmitted drug resistance variants among treatment Naïve patients, 5 years after active introduction of HAART in Kuala Lumpur, Malaysia.
    Ong LY; Razak SN; Lee YM; Sri La Sri Ponnampalavanar S; Syed Omar SF; Azwa RI; Tee KK; Kamarulzaman A
    J Med Virol; 2014 Jan; 86(1):38-44. PubMed ID: 24127302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic diversity of human immunodeficiency virus-1 isolates in Paraná, Brazil.
    Toledo PV; Carvalho DS; Rossi SG; Brindeiro R; de Queiroz-Telles F
    Braz J Infect Dis; 2010; 14(3):230-6. PubMed ID: 20835505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotypic resistance to antiretroviral drugs in patients infected with several HIV type 1 genetic forms in Cuba.
    Pérez L; Alvarez LP; Carmona R; Aragonés C; Delgado E; Thomson MM; González Z; Contreras G; Pérez J; Nájera R
    AIDS Res Hum Retroviruses; 2007 Mar; 23(3):407-14. PubMed ID: 17411374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in Santos, Brazil.
    de Sa-Filho DJ; Soares Mda S; Candido V; Gagliani LH; Cavaliere E; Diaz RS; Caseiro MM
    AIDS Res Hum Retroviruses; 2008 Mar; 24(3):347-53. PubMed ID: 18327988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and distribution of HIV type 1 genetic diversity and protease inhibitor resistance-associated mutations in Shanghai, P. R. China.
    Zhong P; Kang L; Pan Q; Konings F; Burda S; Ma L; Xue Y; Zheng X; Jin Z; Nyambi P
    J Acquir Immune Defic Syndr; 2003 Sep; 34(1):91-101. PubMed ID: 14501800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultradeep sequencing of B and non-B HIV-1 subtypes: Viral diversity and drug resistance mutations before and after one month of antiretroviral therapy in naive patients.
    Epaulard O; Signori-Schmuck A; Larrat S; Kulkarni O; Blum MG; Fusillier K; Blanc M; Leclercq P; François O; Morand P
    J Clin Virol; 2017 Oct; 95():13-19. PubMed ID: 28830014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral drug resistance and HIV-1 subtypes among treatment-naive prisoners in Kelantan, Malaysia.
    Ariffin TA; Mohamad S; Yusuf WN; Shueb RH
    J Infect Dev Ctries; 2014 Aug; 8(8):1063-7. PubMed ID: 25116676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of distinct human immunodeficiency virus type 1 circulating recombinant forms in northeast Brazil.
    Santos LA; Monteiro-Cunha JP; Araujo AF; Brites C; Galvao-Castro B; Alcantara LC
    J Med Virol; 2011 Dec; 83(12):2066-72. PubMed ID: 22012712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moderate prevalence of transmitted drug resistance and high HIV-1 genetic diversity in patients from Mato Grosso State, Central Western Brazil.
    Ferreira AS; Cardoso LP; Stefani MM
    J Med Virol; 2011 Aug; 83(8):1301-7. PubMed ID: 21678433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phylogenetic analysis of HIV-1 subtypes and drug resistance profile among treatment-naïve people in Kuwait.
    Chehadeh W; Albaksami O; Altawalah H; Ahmad S; Madi N; John SE; Abraham PS; Al-Nakib W
    J Med Virol; 2015 Sep; 87(9):1521-6. PubMed ID: 25976289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral drug resistance and phylogenetic diversity of HIV-1 in Chile.
    Ríos M; Delgado E; Pérez-Alvarez L; Fernández J; Gálvez P; de Parga EV; Yung V; Thomson MM; Nájera R
    J Med Virol; 2007 Jun; 79(6):647-56. PubMed ID: 17457921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of resistance-associated mutations to protease and reverse transcriptase inhibitors in treatment-naïve (HIV1)-infected individuals in Casablanca, Morocco.
    Bakhouch K; Oulad-Lahcen A; Bensghir R; Blaghen M; Elfilali KM; Ezzikouri S; Abidi O; Hassar M; Wakrim L
    J Infect Dev Ctries; 2009 Jun; 3(5):380-91. PubMed ID: 19759509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-circulation HIV-1 subtypes B, C, and CRF31_BC in a drug-naïve population from Southernmost Brazil: analysis of primary resistance mutations.
    de Medeiros RM; Junqueira DM; Matte MC; Barcellos NT; Chies JA; Matos Almeida SE
    J Med Virol; 2011 Oct; 83(10):1682-8. PubMed ID: 21837783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profile of HIV type 1 infection and genotypic resistance mutations to antiretroviral drugs in treatment-naive HIV type 1-infected individuals in Hai Phong, Viet Nam.
    Ishizaki A; Cuong NH; Thuc PV; Trung NV; Saijoh K; Kageyama S; Ishigaki K; Tanuma J; Oka S; Ichimura H
    AIDS Res Hum Retroviruses; 2009 Feb; 25(2):175-82. PubMed ID: 19239356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subtype and genotypic resistance analysis of HIV-1 infected patients in Austria.
    Falkensammer B; Doerler M; Kessler HH; Puchhammer-Stoeckl E; Parson W; Duftner C; Dierich MP; Stoiber H
    Wien Klin Wochenschr; 2007; 119(5-6):181-5. PubMed ID: 17427022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus type 1 (HIV-1) genotyping in Rio de Janeiro, Brazil: assessing subtype and drug-resistance associated mutations in HIV-1 infected individuals failing highly active antiretroviral therapy.
    Couto-Fernandez JC; Silva-de-Jesus C; Veloso VG; Rachid M; Gracie RS; Chequer-Fernandez SL; Oliveira SM; Arakaki-Sanchez D; Chequer PJ; Morgado MG
    Mem Inst Oswaldo Cruz; 2005 Feb; 100(1):73-8. PubMed ID: 15867968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV type 1 diversity in France, 1999-2001: molecular characterization of non-B HIV type 1 subtypes and potential impact on susceptibility to antiretroviral drugs.
    Fleury H; Recordon-Pinson P; Caumont A; Faure M; Roques P; Plantier JC; Couturier E; Dormont D; Masquelier B; Simon F;
    AIDS Res Hum Retroviruses; 2003 Jan; 19(1):41-7. PubMed ID: 12596719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High incidence of non-B and recombinant HIV-1 strains in newly diagnosed patients in Galicia, Spain: study of genotypic resistance.
    Pérez-Alvarez L; Carmona R; Muñoz M; Delgado E; Thomson MM; Contreras G; Pedreira JD; Rodríguez Real R; Vázquez de Parga E; Medrano L; Taboada JA; Nájera R;
    Antivir Ther; 2003 Aug; 8(4):355-60. PubMed ID: 14518705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of HIV type 1 subtype on drug resistance mutations in Nigerian patients failing first-line therapy.
    Chaplin B; Eisen G; Idoko J; Onwujekwe D; Idigbe E; Adewole I; Gashau W; Meloni S; Sarr AD; Sankalé JL; Ekong E; Murphy RL; Kanki P
    AIDS Res Hum Retroviruses; 2011 Jan; 27(1):71-80. PubMed ID: 20964479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.